Active — Not RecruitingNot Applicable

Characteristics and Prognostic Outcomes of Diaphragmatic Ultrasound in Myasthenia Gravis

China100 participantsStarted 2024-07-01

Plain-language summary

The goal of this observational study is to learn about the characteristics and prognostic outcomes of diaphragmatic ultrasound in myasthenia gravis. The main question it aims to answer is: Does diaphragmatic ultrasound predict prognosis of myasthenia gravis in six months? Participants diagnosed as myasthenia gravis will take the diaphragm ultrasound examinations.

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * 1: Patients who seek treatment at the First Affiliated Hospital of Chongqing Medical University and have fluctuating skeletal muscle weakness and at least one of the following three conditions will be included: positive reaction to cholinesterase inhibitors 2: Serum positive antibodies against acetylcholine receptors, muscle specific kinases, or lipoprotein related proteins 3: Repeated electrical stimulation examination showed a decrease in wave amplitude. Exclusion Criteria: * 1: Patients with lung disease or heart failure, or a history of non-invasive ventilator or tracheotomy

What they're measuring

QMG changes

Timeframe: 6 months

Trial details

NCT IDNCT06707727

SponsorFirst Affiliated Hospital of Chongqing Medical University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2025-12-31

View on ClinicalTrials.gov More Myasthaenia Gravis trials